Home » Authors » Glen Harris

Articles by Glen Harris

Medicines Co. Snares HDL Drug in Potential $410M Pfizer Deal

Nov. 1, 2011

No Abstract

Kosan Cuts Staff, Adds CEO and Focuses on its Pipeline

Nov. 1, 2011

No Abstract

PDL Divestiture Continues in $170M Deal with EKR

Nov. 1, 2011

No Abstract

Phenomix Seeking $86M IPO to Push Diabetes Candidate

Nov. 1, 2011

No Abstract

Regeneron Signs Another Deal For A Potential $120M Payoff

Nov. 1, 2011

No Abstract

Arginetix, Immune Control Merge Two Corridors in Vascular Space

June 18, 2010

Alvine Brings in Another $21M to Fund Celiac Disease Studies

Sep. 16, 2009

NPS Boosts Treasury with $40M Equity Financing for Pivotal Trials

Aug. 7, 2009

Infinity Halts Tumor Trial Due to High Mortality Data

April 16, 2009

Lean Sunesis Gets Flush with $43.5M Placement

April 2, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...